ArrowMark Colorado Holdings LLC 13D and 13G filings for Viking Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 5:28 pm Sale |
2021-12-31 | 13G | Viking Therapeutics, Inc. VKTX |
ArrowMark Colorado Holdings LLC | 15,931 0.020% |
-7,044,872 (-99.77%) |
Filing |
| 2022-02-14 2:51 pm Sale |
2021-12-31 | 13G | Viking Therapeutics, Inc. VKTX |
ArrowMark Colorado Holdings LLC | 7,060,803 9.030% |
-1,446,987 (-17.01%) |
Filing |
| 2021-02-16 1:29 pm Sale |
2020-12-31 | 13G | Viking Therapeutics, Inc. VKTX |
ArrowMark Colorado Holdings LLC | 8,507,790 11.700% |
-305,788 (-3.47%) |
Filing |